Skip to main content
Focused investors/ValueAct Capital

ValueAct Capital

As of Q2 2026, ValueAct Capital reported 18 long-equity positions worth $5.63B in aggregate.

Copy-investor backtest

Latest quarter
+11.81%
1-year
-6.13%
3-year
+68.78%
5-year
+54.42%
3-year vs S&P 500
-4.46%
5-year vs S&P 500
-19.26%
5-year top 5
+37.05%

Return from mechanically copying the disclosed 13F equity portfolio after each filing and rebalancing at the next. The vs S&P 500 figures subtract SPY over that manager's own rebalance dates, so both sides cover the same days; both are price return, excluding dividends. Method & limitations.

Get email alerts when ValueAct Capital files a new 13F — sign in or create a free account.

Updated 2026-06-06 from SEC 13F data.

Live quotes available for 4 of 17 rows. Rows without a quote are marked unavailable.

1VRXVALEANT PHARMACEUTICALS INTL COM20.78%Add +78.1%26,959,901$675.35MNo quoteNo quote
2ITGARTNER GROUP INC NEW-CL A COM15.21%Reduce -19.2%16,790,013$494.3M$29.44No quote
3SLESARA LEE CORP COM14.43%-34,918,822$468.96MNo quoteNo quote
4VRSNVERISIGN INC COM11.55%Add +3.7%11,832,069$375.55M$31.74No quote
5BCRC R BARD INC COM10.64%Add +44.3%4,246,844$345.82MNo quoteNo quote
6WSHWILLIS GROUP HOLDINGS PUBLIC SHS8.21%Add +12.2%8,656,910$266.81MNo quoteNo quote
7SNASNAP ON TOOLS CORP COM6.62%Add +26.6%4,625,395$215.13M$46.51No quote
8ALRALERE INC COM4.97%New5,228,282$161.71MNo quoteNo quote
9BLUDIMMUCOR INC COM4.60%-7,540,665$149.53MNo quoteNo quote
10KARKAR AUCTION SERVICES INC COM0.88%-2,258,828$28.48MNo quoteNo quote
11VRSKVERISK ANALYTICS INC CL A COM0.86%New1,000,000$28.01M$28.01No quote
12PLCMPOLYCOM INC COM0.55%New650,000$17.73MNo quoteNo quote
13ESENERGY SOLUTIONS INC COM0.39%-2,495,218$12.55MNo quoteNo quote
14ALRPRBALERE INC PERP PFD CONV SE0.33%New48,994$10.78MNo quoteNo quote
17NTYNBTY INC COM-Sold0$0No quoteNo quote
16IMAPRBINVERNESS MEDICAL INNOVATIONS PFDCONVSERB-Sold0$0No quoteNo quote
15IMAINVERNESS MEDICAL INNOVATIONS COM-Sold0$0No quoteNo quote